EXEL
Conviction 88HealthcareScan · Thu, Sep 24, 2026Exelixis, Inc. (EXEL) closed at $57.95 (+2.14%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 87, -2.0% from its 52-week high, +33.0% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
Financials as of Fri, Jul 3, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 171 scan
- Broke outSep 21 scan
Recent news
- Exelixis (EXEL) Gets FDA Review Extension For Zanzalintinib განაცხად tometastatic Colorectal CancerYahoo Finance · Mon, Sep 21, 2026
- Exelixis, Inc. (EXEL) Stock Analysis: Navigating Biotech with Strong Revenue Growth and Strategic CollaborationsDirectorsTalk Interviews · Mon, Sep 21, 2026
- Exelixis (EXEL) Slips 0.22% to $58.36, Key Support and Resistance in Focus - Risk Reward Setupscareplusvn.com · Sun, Sep 20, 2026
- Exelixis (EXEL) Slips 0.22% to $58.36, Key Support and Resistance in Focus - NAAIM Leveragedars.gov.et · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in EXEL
Insider activity
SEC Form 4 transactions in EXEL · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Beckerle Mary C Director · Common Stock · 2026-08-10 | Sell | 9.81K | $527K | 2026-08-10 | 2026-08-12 |
WYSZOMIERSKI JACK L Director · Common Stock · 2026-06-01 | Sell | 3.92K | $198K | 2026-06-01 | 2026-06-03 |
Eckhardt Sue Gail Director · Common Stock · 2026-06-01 | Sell | 9.81K | $492K | 2026-06-01 | 2026-06-03 |
Oliver Bob Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Smith Julie Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
JOHNSON DAVID EDWARD Director · Option (right to buy) · 2026-05-27 | Grant | 19.13K | $0 | 2026-05-27 | 2026-05-29 |
Eckhardt Sue Gail Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Freire Maria C Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Beckerle Mary C Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Heyman Tomas J. Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
SEC filings
EDGAR filings in EXEL · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.